記者從日前在京召開的2011年針灸國際研討會上獲悉，首都醫(yī)科大學附屬北京中醫(yī)醫(yī)院針灸中心經(jīng)臨床研究證實，傳統(tǒng)的中醫(yī)針灸療法可有效預防偏頭痛的復發(fā)和加重。相關(guān)研究論文近日發(fā)表在國際著名醫(yī)學期刊《疼痛》上，成為中國大陸首篇發(fā)表于該雜志的臨床研究論文,。該文還被國際知名醫(yī)學生物學機構(gòu)Faculty of 1000 medicine（千名醫(yī)學家）收錄。
據(jù)了解,，作為臨床常見病之一,，偏頭痛發(fā)病率高，且危害嚴重,。目前,，我國18歲~65歲人群的偏頭痛患病率高達9.3%，且有逐年升高趨勢,。針灸治療頭痛在中國已經(jīng)有數(shù)千年的歷史,。北京中醫(yī)醫(yī)院針灸中心自2004年設立頭痛專家門診，開展了基于“金針王樂亭”,、國醫(yī)大師賀普仁等多位著名針灸學家治痛經(jīng)驗的頭痛研究,。
據(jù)該中心主任王麟鵬介紹，該項目采取單盲,、雙模擬,、隨機對照的形式，在國內(nèi)5家醫(yī)院的針灸科共招募140名無先兆偏頭痛患者,，隨機分為兩組,，分別為治療組（針灸加安慰劑）和對照組（假針加氟桂利嗪）。兩組患者每周針灸治療3次,，每晚口服藥物,。結(jié)果顯示，4周后,，治療組偏頭痛的有效緩解率為59%,，對照組為40%；治療組疼痛天數(shù)平均下降4.1天,，對照組平均下降1.9天,。16周后,，治療組有效緩解率為56%，對照組為37%,；治療組疼痛天數(shù)平均下降4.1天,，對照組平均下降2天。
研究人員據(jù)此認為,，針灸可以作為偏頭痛的預防復發(fā)和加重的方法,，其治療效果也優(yōu)于此前國外的相關(guān)研究。由于其研究方法的新穎和重要性,，該論文還被國際知名醫(yī)學生物學機構(gòu)“千名科學家”收錄,。（生物谷 Bioon.com）
doi:10.1016/j.pain.2011.04.006
PMC:
PMID:
Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial
Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li
Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were available to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual analogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P<.05), whereas there were no significant differences between the 2 groups in VAS scores and SF-36 physical and mental component summary scores (P>.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.
